IN2015DN00515A - - Google Patents
Info
- Publication number
- IN2015DN00515A IN2015DN00515A IN515DEN2015A IN2015DN00515A IN 2015DN00515 A IN2015DN00515 A IN 2015DN00515A IN 515DEN2015 A IN515DEN2015 A IN 515DEN2015A IN 2015DN00515 A IN2015DN00515 A IN 2015DN00515A
- Authority
- IN
- India
- Prior art keywords
- microglobulin
- alpha
- treatment
- relates
- present
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A61K38/1722—Plasma globulins, lactoglobulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Marine Sciences & Fisheries (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Psychology (AREA)
- Nutrition Science (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pulmonology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201270538 | 2012-09-05 | ||
| DKPA201270557 | 2012-09-12 | ||
| PCT/EP2013/068270 WO2014037390A1 (en) | 2012-09-05 | 2013-09-04 | Alpha-1-microglobulin for use in the treatment of mitochondria-related diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2015DN00515A true IN2015DN00515A (pt) | 2015-06-26 |
Family
ID=49162118
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN515DEN2015 IN2015DN00515A (pt) | 2012-09-05 | 2013-09-04 |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US10226507B2 (pt) |
| EP (1) | EP2900254B1 (pt) |
| JP (2) | JP2015533790A (pt) |
| KR (1) | KR20150047510A (pt) |
| CN (1) | CN104661673A (pt) |
| AU (1) | AU2013311714C1 (pt) |
| BR (1) | BR112015003957A2 (pt) |
| CA (1) | CA2881321A1 (pt) |
| DK (1) | DK2900254T3 (pt) |
| EA (1) | EA028963B1 (pt) |
| ES (1) | ES2599034T3 (pt) |
| HK (1) | HK1210585A1 (pt) |
| HR (1) | HRP20161364T1 (pt) |
| HU (1) | HUE030559T2 (pt) |
| IN (1) | IN2015DN00515A (pt) |
| MX (1) | MX357656B (pt) |
| NZ (1) | NZ629621A (pt) |
| PL (1) | PL2900254T3 (pt) |
| PT (1) | PT2900254T (pt) |
| SG (1) | SG11201500669SA (pt) |
| WO (1) | WO2014037390A1 (pt) |
| ZA (1) | ZA201500547B (pt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016204360A (ja) * | 2015-02-25 | 2016-12-08 | エー１エム ファーマ エービーＡ１Ｍ Ｐｈａｒｍａ ＡＢ | 放射性核種療法における腎臓の保護に用いるためのアルファ−１−ミクログロブリン |
| KR20180116385A (ko) * | 2016-02-25 | 2018-10-24 | 에이원엠 파마 에이비 | 조영제의 사용과 관련하여 신장 보호에서 이용하기 위한 알파-1-마이크로글로불린 |
| EA039776B1 (ru) | 2016-03-18 | 2022-03-11 | Гард Терапьютикс Интернэшнл Айби | Новые белки, полученные из альфа-1-микроглобулина, и их применение |
| GB2566516A (en) | 2017-09-15 | 2019-03-20 | Univ Oxford Innovation Ltd | Electrochemical recognition and quantification of cytochrome c oxidase expression in bacteria |
| CN109867717A (zh) * | 2019-04-01 | 2019-06-11 | 山西瑞亚力生物技术有限公司 | 一种血浆中α1微球蛋白的提取方法 |
| CN110452980B (zh) * | 2019-09-23 | 2023-07-28 | 武汉儿童医院 | 一种线粒体脑肌病诊断试剂盒及应用 |
| US20220362293A1 (en) * | 2019-09-25 | 2022-11-17 | Cytegen Corp. | Treatment of Mitochondrial Deficits and Age-Related Diseases Using Blood Products |
| CN115575646B (zh) * | 2022-11-21 | 2023-04-28 | 四川大学华西医院 | 一种代谢标志物组在制备预测癫痫发作的试剂盒中的用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2547124A1 (en) * | 2003-11-26 | 2005-06-09 | Sanofi-Aventis Deutschland Gmbh | Tubular proteinuria as an indicator for elevated cardiovascular risk |
| AU2008214837B2 (en) * | 2007-02-12 | 2013-01-10 | A1M Pharma Ab | Diagnosis and treatment of preeclampsia |
| WO2009098682A2 (en) * | 2008-02-04 | 2009-08-13 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Methods and compositions for treatment of mitochondrial disorders |
| EP2313106B1 (en) * | 2008-07-18 | 2016-03-30 | A1M Pharma AB | Medical use of the radical scavenger and antioxidant alpha-1-microglobulin |
-
2013
- 2013-09-04 CA CA2881321A patent/CA2881321A1/en not_active Abandoned
- 2013-09-04 ES ES13759995.7T patent/ES2599034T3/es active Active
- 2013-09-04 AU AU2013311714A patent/AU2013311714C1/en not_active Ceased
- 2013-09-04 EP EP13759995.7A patent/EP2900254B1/en not_active Not-in-force
- 2013-09-04 PL PL13759995T patent/PL2900254T3/pl unknown
- 2013-09-04 WO PCT/EP2013/068270 patent/WO2014037390A1/en active Application Filing
- 2013-09-04 US US14/423,260 patent/US10226507B2/en not_active Expired - Fee Related
- 2013-09-04 DK DK13759995.7T patent/DK2900254T3/en active
- 2013-09-04 EA EA201590503A patent/EA028963B1/ru not_active IP Right Cessation
- 2013-09-04 BR BR112015003957A patent/BR112015003957A2/pt not_active Application Discontinuation
- 2013-09-04 CN CN201380043567.0A patent/CN104661673A/zh active Pending
- 2013-09-04 KR KR1020157005748A patent/KR20150047510A/ko not_active Application Discontinuation
- 2013-09-04 HU HUE13759995A patent/HUE030559T2/en unknown
- 2013-09-04 PT PT137599957T patent/PT2900254T/pt unknown
- 2013-09-04 MX MX2015002604A patent/MX357656B/es active IP Right Grant
- 2013-09-04 SG SG11201500669SA patent/SG11201500669SA/en unknown
- 2013-09-04 JP JP2015530375A patent/JP2015533790A/ja active Pending
- 2013-09-04 NZ NZ629621A patent/NZ629621A/en not_active IP Right Cessation
- 2013-09-04 IN IN515DEN2015 patent/IN2015DN00515A/en unknown
-
2015
- 2015-01-23 ZA ZA2015/00547A patent/ZA201500547B/en unknown
- 2015-09-15 HK HK15109002.0A patent/HK1210585A1/xx not_active IP Right Cessation
-
2016
- 2016-10-19 HR HRP20161364TT patent/HRP20161364T1/hr unknown
-
2018
- 2018-08-24 JP JP2018157394A patent/JP2018203756A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ES2599034T3 (es) | 2017-01-31 |
| CN104661673A (zh) | 2015-05-27 |
| MX2015002604A (es) | 2015-06-10 |
| JP2015533790A (ja) | 2015-11-26 |
| EP2900254B1 (en) | 2016-08-03 |
| CA2881321A1 (en) | 2014-03-13 |
| HUE030559T2 (en) | 2017-05-29 |
| HRP20161364T1 (hr) | 2016-12-16 |
| DK2900254T3 (en) | 2016-08-29 |
| AU2013311714A1 (en) | 2015-03-12 |
| EP2900254A1 (en) | 2015-08-05 |
| AU2013311714C1 (en) | 2018-01-25 |
| MX357656B (es) | 2018-07-18 |
| HK1210585A1 (en) | 2016-04-29 |
| JP2018203756A (ja) | 2018-12-27 |
| BR112015003957A2 (pt) | 2017-08-08 |
| AU2013311714B2 (en) | 2017-10-12 |
| SG11201500669SA (en) | 2015-02-27 |
| NZ629621A (en) | 2015-09-25 |
| WO2014037390A1 (en) | 2014-03-13 |
| US10226507B2 (en) | 2019-03-12 |
| KR20150047510A (ko) | 2015-05-04 |
| PT2900254T (pt) | 2016-10-18 |
| EA028963B1 (ru) | 2018-01-31 |
| US20150258171A1 (en) | 2015-09-17 |
| EA201590503A1 (ru) | 2015-06-30 |
| PL2900254T3 (pl) | 2017-02-28 |
| ZA201500547B (en) | 2017-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2015DN00515A (pt) | ||
| HK1222552A1 (zh) | 索布替羅用於治療髓鞘形成疾病 | |
| MX356728B (es) | Combinación farmacéutica para usar en el tratamiento de pacientes que padecen diabetes de tipo 2. | |
| HUE056006T2 (hu) | Kombináció Parkinson-kór kezelésére | |
| MX2021004211A (es) | Composiciones vacuna. | |
| MX349224B (es) | Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa. | |
| AP2014007399A0 (en) | Phenyl-3-AZA-bicycloÄ3.1.0Ühex-3-YL-methanones andthe use thereof as medicament | |
| EP2822558A4 (en) | PROCASPASE 3 ACTIVATION BY COMBINATION THERAPY | |
| GB201511770D0 (en) | Novel pharmaceutical formulationsand their use in the treatment of periodontal disease | |
| IL235429A0 (en) | (r)-nifortal, its use in the treatment of infections and the preparation of (r) and (s)-nifortal | |
| HK1215794A1 (zh) | 用於治療疾病的同種異體自噬體富集組合物 | |
| GB201502079D0 (en) | Improvements in, or relating to, caskets or coffins | |
| EP2825194A4 (en) | USE OF ANTITHROMBINE IN THE TREATMENT OF PRE-ECLAMPSIA | |
| UA117567C2 (uk) | Композиція, яка стимулює лактацію, на основі фосфатидилсерину | |
| IN2014KN01772A (pt) | ||
| ZA201500652B (en) | Medicine againts gastroesephageal reflux disease | |
| BR112015023730A2 (pt) | uso de sedoeptulose como suplemento nutricional | |
| CY1117740T1 (el) | Χρηση του odiparcil στη θεραπεια μιας μυκοπολυσακχαριδωσης | |
| GB201310748D0 (en) | Student's clinic | |
| UA24322S (uk) | Стамеска пасічника | |
| FI20115180L (fi) | Koostumus käytettäväksi sairauden hoidossa | |
| UA75904U (xx) | Стоматологічний комплект "sadaf dent streg" | |
| UA80618U (en) | Use of n-steroylethanolamine as radiomodifier | |
| IN2012DE01204A (en) | "shikhar technology" | |
| MX2015001134A (es) | Compuestos terapeuticos. |